XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split

By: Quiver PriceTracker

Posted: an hour ago / April 21, 2026 2:50 p.m. UTC

XRTX

XORTX Therapeutics Inc. (XRTX) is up 22.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most direct catalyst appears to be the company’s announcement that it received a Nasdaq compliance letter for the $1.00 minimum bid requirement, removing a near-term delisting overhang. With micro-cap biotech names, clearing an exchange compliance issue can also spark short-term momentum buying and improve trading liquidity.

Details:

The company said Nasdaq’s Listing Qualifications Department issued a compliance letter tied to the $1.00 minimum bid requirement, stating the deficiency has been cured.

XORTX said the compliance was achieved after its common shares traded at or above $1.00 for at least 10 consecutive trading days, following a 1-for-5 reverse split effective April 6, 2026.

The company stated the bid-price requirement was met on April 17, 2026, and it received the compliance letter on April 20, 2026.

Separately, XORTX recently closed its acquisition of the VB4-P5 kidney anti-fibrotic program from Vectus in an equity-and-warrant transaction, expanding its pipeline and potentially adding to recent investor attention.

Sources:

XORTX Therapeutics (press release), SEC, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$XRTX Hedge Fund Activity

We have seen 5 institutional investors add shares of $XRTX stock to their portfolio, and 3 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DRW SECURITIES, LLC added 193,599 shares (+inf%) to their portfolio in Q4 2025, for an estimated $108,802
CITADEL ADVISORS LLC removed 86,326 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $48,515
BAADER BANK AKTIENGESELLSCHAFT added 18,732 shares (+inf%) to their portfolio in Q4 2025, for an estimated $10,527
XTX TOPCO LTD removed 13,820 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $7,766
TWO SIGMA SECURITIES, LLC added 12,597 shares (+inf%) to their portfolio in Q4 2025, for an estimated $7,079
ROYAL BANK OF CANADA added 3,733 shares (+1042.7%) to their portfolio in Q4 2025, for an estimated $2,097
UBS GROUP AG added 1,167 shares (+498.7%) to their portfolio in Q4 2025, for an estimated $655

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.